Reach Neuro raises $2M in November 2026 SEC filing

- Raised in SEC filings
- $2.2M
- Filings
- 2
- Latest est. round
- Seed
- Incorporated
- 2021
- Industry
- Health care
- Based in
- RI
Reach Neuro, a Rhode Island-based company in the Other Health Care industry, first filed with the SEC in August 2022. This filing reported a $200K sale on July 29, 2022, for an estimated pre-seed or seed round. The company was incorporated in 2021.
The company's second filing in November 2026 reported a $2M sale on October 30, 2026, for an estimated seed round. This shows an increase in the amount raised between the two rounds. Total estimated funding is $2.2M.
The latest filing names Jennifer Ernst as an executive officer and director. Thorne Sparkman, Marco Capogrosso, Douglas Weber, and Jordi Parramon are also named as directors. Find Your Role does not track open roles for Reach Neuro yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-10-30 | $2M | Seed |
| 2022-07-29 | $200K | Pre-seed/Seed |
Named in the latest filing
- Jennifer Ernst
- Thorne Sparkman
- Marco Capogrosso
- Douglas Weber
- Jordi Parramon
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR